Gemini answer: Conclusion: The Intentional Narrative Skew The omission of UCLA's clinical role appears to be an editorial choice to heavily favor the narrative of manufacturing resilience and technological innovation (Eden, Flaskworks, Advent, Zeon). The author focuses on answering the question: "How do you mass-produce instruction?" The result is a brilliant review of the engineering and supply chain, but one that sacrifices the clinical history that provided the initial justification for the entire enterprise.
Weird no mention of UCLA in this extensive review. Wonder why?
Andrew has many times over cited UCLA's clinical and pivotal role in the evolution of DCVAX.
So I would ask, where were you, when Andrew cited UCLA at nauseum in a clinical context, but pop-up here with a flippant response to serve your ego, and clearly not, to the benefit of shareholders?